Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad.
- DOI
- 10.1007/s10198-011-0336-9
- Published
- 2011 Oct
- Container
- The European journal of health economics : HEPAC : health economics in prevention and care
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10198-011-0336-9,
title = {Pharmaceutical patents, R\&D incentives and access to new drugs: new ways of progress at the crossroad.},
author = {Antoñanzas F and Juárez-Castelló C and Rodríguez-Ibeas R},
year = {2011},
journal = {The European journal of health economics : HEPAC : health economics in prevention and care},
doi = {10.1007/s10198-011-0336-9},
url = {https://doi.org/10.1007/s10198-011-0336-9}
}RIS
TY - JOUR TI - Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad. AU - Antoñanzas F AU - Juárez-Castelló C AU - Rodríguez-Ibeas R PY - 2011 JO - The European journal of health economics : HEPAC : health economics in prevention and care DO - 10.1007/s10198-011-0336-9 UR - https://doi.org/10.1007/s10198-011-0336-9 ER -
APA
F, A., C, J., & R, R. (2011). Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad.. The European journal of health economics : HEPAC : health economics in prevention and care. https://doi.org/10.1007/s10198-011-0336-9
Source records
- pubmed · retrieved 2026-09-26T05:46:51.799Z